|
000
| 01814nam 2200361zi 4500 |
|---|
| 001 | 9.934805 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20240830161526 |
|---|
| 006 | m o d f |
|---|
| 007 | cr mn||||||||| |
|---|
| 008 | 240301t20242024onc o f000 0 eng d |
|---|
| 020 | |a9780660705712 |
|---|
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aHP40-353/2024E-PDF |
|---|
| 245 | 00|aVaccine administration : |ba guide to selecting needle gauge and length. |
|---|
| 264 | 1|a[Ottawa] : |bPublic Health Agency of Canada = Agence de la santé publique du Canada, |c[2024]. |
|---|
| 264 | 4|c©2024 |
|---|
| 300 | |a1 online resource (2 unnumbered pages) : |billustrations |
|---|
| 336 | |atext|btxt|2rdacontent |
|---|
| 337 | |acomputer|bc|2rdamedia |
|---|
| 338 | |aonline resource|bcr|2rdacarrier |
|---|
| 500 | |aCaption title. |
|---|
| 500 | |aIssued also in French under title: Administration des vaccins : un guide de sélection du calibre et de la longueur des aiguilles. |
|---|
| 520 | |a"Selection of the right needle should be based on the route, recipient’s factors (e.g., age, muscle mass), and vaccine properties. This is to optimize the immune response and reduce the risk of injection site reactions ... The use of safety-engineered needles and syringes (e.g., protected needle devices) is preferred and, in many jurisdictions, mandated by law to reduce risk of injury"--Page [1]. |
|---|
| 650 | 0|aVaccination|zCanada. |
|---|
| 650 | 0|aImmunization|zCanada. |
|---|
| 650 | 0|aInjections, Intramuscular|zCanada. |
|---|
| 650 | 0|aInjections, Intradermal|zCanada. |
|---|
| 650 | 0|aPublic health|zCanada. |
|---|
| 710 | 2 |aPublic Health Agency of Canada, |eissuing body. |
|---|
| 775 | 08|tAdministration des vaccins : |w(CaOODSP)9.934806 |
|---|
| 856 | 40|qPDF|s2.65 MB|uhttps://publications.gc.ca/collections/collection_2024/aspc-phac/HP40-353-2024-eng.pdf |
|---|